Next Article in Journal
In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients
Next Article in Special Issue
Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management
Previous Article in Journal
Plasma Biomarkers and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: New Tools for Better Patient Selection?
 
 
Review

Article Versions Notes

Cancers 2019, 11(9), 1270; https://doi.org/10.3390/cancers11091270
Action Date Notes Link
article xml file uploaded 29 August 2019 12:09 CEST Original file -
article xml uploaded. 29 August 2019 12:09 CEST Update https://www.mdpi.com/2072-6694/11/9/1270/xml
article pdf uploaded. 29 August 2019 12:09 CEST Version of Record https://www.mdpi.com/2072-6694/11/9/1270/pdf
article html file updated 29 August 2019 12:11 CEST Original file -
article html file updated 13 February 2020 13:29 CET Update -
article html file updated 20 July 2022 04:23 CEST Update https://www.mdpi.com/2072-6694/11/9/1270/html
Back to TopTop